Skip to main content

NEW YORK (TheStreet) -- RATINGS CHANGES

Abbvie (ABBV) - Get AbbVie, Inc. Report was upgraded to overweight from equal-weight. Twelve-month price target is $60. Company has an attractive pipeline and can generate healthy growth over the coming quarters, Morgan Stanley said.

Fortress Investmentundefined was downgraded to hold at TheStreet Ratings.

FirstEnergy (FE) - Get FirstEnergy Corp. Report was upgraded at Jefferies to buy from hold. Valuation call with 12-month price target of $37, Jefferies said.

GNC (GNC) - Get GNC Holdings, Inc. Class A Report was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $40. Company has a lackluster outlook for the remainder of the year, Deutsche Bank said.

[Read: Why Whole Foods Market Is Falling This Morning]

Hilton (HLT) - Get Hilton Worldwide Holdings Inc Report was upgraded at Morgan Stanley to overweight. Twelve-month price target is $27. Company has strong fundamentals and there is upside for Waldorf Astoria valuation, Morgan Stanley said.

Hilton was upgraded at MKM Partners to buy from neutral. Twelve-month price target is $27. Stock has underperformed, but has near-term catalysts, MKM Partners said.

Infinity Pharmaceutical (INFI) - Get Infinity Pharmaceuticals, Inc. Report was upgraded at Jefferies to buy from hold. Commerical competitiveness already priced in and risk/reward is attractive, Jefferies said. Twelve-month price target is $13. Buy rating.

J.C. Penney (JCP) - Get J. C. Penney Company, Inc. Report was upgraded at UBS to neutral from sell. Less downside in SSS/GM risk for near term, UBS said. Twelve-month price target is $9.

Intelligent Systems (INS) - Get Intelligent Systems Corporation Report was downgraded to hold at TheStreet Ratings.

Marriott (MAR) - Get Marriott International, Inc. Class A Report was downgraded at Morgan Stanley to equal-weight. Twelve-month price target is $64. Valuation call, as the stock has outperformed its peers by 14% year to date, Morgan Stanley said.

[Read: Imagine Twitter at $140 a Share]

TheStreet Recommends

Merck (MRK) - Get Merck & Co., Inc. Report was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $60. Stock has outperformed and risk reward now balanced, Morgan Stanley said.

Fresh Market (TFM) was downgraded at Sterne Agee to underperform. Twelve-month price target is $29. Industry competition is heating up, Sterne Agee said.

TripAdvisor (TRIP) - Get TripAdvisor, Inc. Report was upgraded at Cantor Fitzgerald to buy from hold. Twelve-month price target is $94. Company is seeing improved shopper monetization and growth, Cantor Fitzgerald said.

Whole Foods (WFM) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $40. Seeing excess capacity in the natural food retail segment, Deutsche Bank said.

Whole Foods was downgraded at Cantor Fitzgerald to sell. Twelve-month price target is $38. Company had poor results across the board, but trades at a premium valuation, Cantor Fitzgerald said.

[Read: 10 Ways to Win Over Your Boss in 30 Days]

Whole Foods was downgraded at Sterne Agee to neutral. Twelve-month price target is $40. Company is becoming more competitive on price, Sterne Agee said.

Whole Foods was downgraded at BMO Capital to market perform. Twelve-month price target is $40. Competition is weighing on the growth outlook, BMO Capital said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook

>>Read More: Target's Biggest Problem May Be Target's Board

>>Read More: Will Crowdfunding Create the Next Martha Stewart?

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.